Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan Biotechnology Promotion Group Reveals Measures To Accelerate New Drug Development

This article was originally published in PharmAsia News

Executive Summary

A public-private sector alliance to promote biotechnology in Japan revealed a plan Dec. 11 to speed up new drug development. Named Dream BT Japan, the plan outlines strategies to promote commercialization of research in induced Pluripotent stem cells and speed up new drug development. Details include budget increases for basic research and educating intellectual property specialists. The group is composed of 18 members, including officers from the Ministries of Health, Agriculture, Trade and Industry, Environment and related experts. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts